Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB) [2]

R. Sorio, E. Galligioni, D. Crivellari, R. Talamini, S. Monfardini

Research output: Contribution to journal › Article › peer-review

ASJC Scopus subject areas

@article{25f4ee4174a0400689f8bab79cffbea2,

title = "Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB) [2]",

author = "R. Sorio and E. Galligioni and D. Crivellari and R. Talamini and S. Monfardini",

year = "1995",

language = "English",

volume = "6",

pages = "306--307",

journal = "Annals of Oncology",

issn = "0923-7534",

publisher = "NLM (Medline)",

number = "3",

}

TY - JOUR

T1 - Survival after treatment of advanced renal cell carcinoma (RCC) with high-dose interleukin-2 (rIL-2) or vinblastine (VLB) [2]

AU - Sorio, R.

AU - Galligioni, E.

AU - Crivellari, D.

AU - Talamini, R.

AU - Monfardini, S.

PY - 1995

Y1 - 1995

UR - http://www.scopus.com/inward/record.url?scp=0028957652&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028957652&partnerID=8YFLogxK

M3 - Article

C2 - 7612500

AN - SCOPUS:0028957652

SN - 0923-7534

VL - 6

SP - 306

EP - 307

JO - Annals of Oncology

JF - Annals of Oncology

IS - 3

ER -